Avalon GloboCare Corp. (NASDAQ:ALBT) Short Interest Update

Avalon GloboCare Corp. (NASDAQ:ALBT) saw a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 137,400 shares, an increase of 64.7% from the March 31st total of 83,400 shares. Based on an average daily volume of 170,800 shares, the days-to-cover ratio is presently 0.8 days. Currently, 2.8% of the shares of the company are sold short.

Avalon GloboCare Stock Performance

Shares of Avalon GloboCare stock opened at $0.27 on Friday. Avalon GloboCare has a one year low of $0.25 and a one year high of $2.42. The stock’s fifty day moving average is $0.34 and its 200 day moving average is $0.46. The stock has a market cap of $3.03 million, a P/E ratio of -0.17 and a beta of 0.19.

Avalon GloboCare (NASDAQ:ALBT) last announced its earnings results on Monday, April 15th. The company reported ($0.90) EPS for the quarter. The company had revenue of $0.32 million during the quarter.

Avalon GloboCare Company Profile

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and China. The company develops and delivers transformative cellular therapeutics, precision diagnostics, and clinical laboratory services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells.